Achieving reliable estimations of cancer risk and functional consequence of BRCA1 and BRCA2 sequence variants represent a potential to improve management, diagnosis, and clinical decisions of inherited breast and ovarian cancers38,46 and computational approaches can enable and support these estimations. The gene discussed is BRCA1; the disease is cancer.